Sight Sciences, Inc. (SGHT) NASDAQ
4.30
-0.24(-5.29%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.30
-0.24(-5.29%)
Currency In USD
Address
4040 Campbell Avenue
Menlo Park, CA 94025
United States of America (the)
Phone
877 266 1144
Sector
Healthcare
Industry
Medical - Devices
Employees
216
First IPO Date
July 15, 2021
| Name | Title | Pay | Year Born |
| Paul Badawi | Co-Founder, President, Chief Executive Officer & Director | 1.01M | 1976 |
| Jeremy Hayden | Chief Legal Officer & Corporate Secretary | 584,254 | 1970 |
| Alison Perry Bauerlein | Chief Operating Officer | 676,654 | 1981 |
| James Rodberg | CFO & Treasurer | 0 | 1984 |
| Brenton Taylor | Executive Vice President of Operations and R&D | 0 | 1981 |
| Mark Papini | Senior Vice President of Interventional Glaucoma | 0 | N/A |
| Steve R. Tamayo Jr. | Vice President and Chief Ethics & Compliance Officer | 0 | N/A |
| David Badawi | Co-Founder, Chief Technology Officer & Director | 0 | 1971 |
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.